Navigation Links
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
Date:9/5/2012

eir implementation including IND filing, mid-stage development, license applications, preparations, approval, label extension and post market phase in the global setting (US, Canada, Europe, Canada, Asia). Prior to Pharmacyclics Dr. Gayko served as VP of Regulatory and Clinical Affairs at Nodality and as Global Regulatory Leader at Amgen, where she had also worked as a Global Program Manager and Senior Clinical Research Manager.

Rick Love is serving as Vice President, Legal. He has over 19 years of experience working as in-house counsel in the biotech/pharma industry. For the past three years, he worked for the IPSEN Group, most recently in the position of Vice-President, Head of Patents, U.S.A. Before IPSEN, he practiced in the areas of intellectual property and corporate law at Tercica. Before Tercica, Mr. Love was the Senior Director, Intellectual Property at InterMune and served for eight years at Genentech as Patent Counsel. He holds a J.D. from Golden Gate University School of Law and a B.A. in Mathematics from Hamilton College.

To access a more complete resume for each of these managers and to review the full management team, visit Pharmacyclics' website at: http://www.pharmacyclics.com/pharmacyclics_management.html

Janssen CollaborationThe partnership with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, is progressing well. Since signing the agreement in December 2011, the companies have established numerous working groups, each with a defined area of responsibility in the overall development plan. Currently there are over 200 dedicated employees in both companies engaged in these Working Groups, forwarding the clinical progress of ibrutinib and ensuring the execution of the Global Development Plan for this compound. The partnership also established a Joint Development and Joint Steering Committee to oversee and
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...  Decision Resources Group finds that the laparoscopic device ... will increase to a value of over $4.3 billion ... in the large direct energy device market. In particular, ... due to the advantages they offer and as new ... Decision Resources Group,s coverage of the U.S. laparoscopic device ...
(Date:12/19/2014)... KANSAS CITY, Kan. , Dec. 18, 2014 ... PETX ), a biopharmaceutical company focused on ... for companion animals, today announced positive results from ... company,s innovative drug for treating pain in dogs ... demonstrated improvements in pain assessment scores that were ...
(Date:12/17/2014)... 17, 2014 Revenue and earnings above ... research and development In the past 2013/14 fiscal ... two percent to EUR 4.287 billion (last year: EUR 4.190 ... percent to EUR 360 million. "Overall, 2013/14 was a successful ... Kaschke , President and CEO of Carl Zeiss AG. "Thanks ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS Asserts its Position in Difficult Environment 2
... SAN DIEGO , April 27 ResMed Inc. (NYSE: RMD ) ... , , ... Boston on May 4, 2010 ; Jefferies Global Life Sciences Conference ... ; William Blair Growth Stock Conference at the Four Seasons in Chicago ...
... 27 Volcano Corporation (Nasdaq: VOLC ), ... guidance tools designed to enhance the diagnosis and treatment ... it has entered into a distribution agreement with AngioScore ... indications in Japan . This is the first ...
Cached Medicine Technology:ResMed Inc. to Present at Upcoming Conferences 2Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan 2Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan 3Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan 4
(Date:12/19/2014)... December 20, 2014 Sweetdressy.com , ... has introduced its newest selection of cheap prom dresses ... very popular in the world and clients can buy ... Meanwhile, these prom dresses feature cool cuts and delicate ... now, targeting the middle-end market. Discount shipping costs are ...
(Date:12/19/2014)... December 19, 2014 SuperCloset raises the ... Rooms. SuperCloset continues to offer indoor growers the most ... of the new SuperClone Rooms with the award winning ... turnkey indoor hydroponic grow room setup. , The SuperClone ... SuperCloset’s SuperPonic SuperCloner 50 . The ...
(Date:12/19/2014)... The print component of Vision and Hearing is distributed ... Star, with a circulation of approximately 230,433 copies and ... distributed nationally through a vast social media strategy and ... outlets. To explore the digital version of the campaign, ... an exclusive interview with Mark DeMontis , sharing his ...
(Date:12/19/2014)... drug users who also use cocaine and amphetamines have ... users, a new study finds. "We know that ... attempt and completed suicide," Didier Jutras-Aswad, a psychiatry professor ... news release. "However, there are many different profiles of ... users were actually more likely to attempt suicide." ...
(Date:12/19/2014)... Diet Doc strives to continue to ... weight loss by combining scientific fast weight ... the company understand that remaining committed to a diet ... carbohydrates and sugars from the diet can cause patients ... weight loss goals. , For this reason, Diet ...
Breaking Medicine News(10 mins):Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 2Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 3Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 4
... , FRIDAY, Sept. 16 (HealthDay News) -- People ... clotting and inflammation have a lower five-year survival rate ... findings should be used to better treat and ensure ... said the research team from Duke University Medical Center ...
... GALVESTON, September 16, 2011 Researchers have shown for the ... cells by binding to and rendering inert protein p53, a ... of Texas Medical Branch may lead to treatments for a ... and appears in the current print issue of the ...
... has awarded $11.3 million to Case Western Reserve University ... for research on gastrointestinal cancers. The funding designates the ... in Gastrointestinal (GI) Cancers recognition extended to just ... is the primary affiliate of Case Western Reserve and ...
... WINSTON-SALEM, N.C. Sept. 16, 2011 A study ... colleagues suggests that a high intake of calcium causes ... absorbers of the mineral. "High dietary intake of ... the explanation for this observation has been elusive," said ...
... (USC) epidemiologists suggests that a high intake of calcium ... good absorbers of the mineral. "High dietary intake ... and this study suggests that these associations are likely ... professor of preventive medicine at the Keck School of ...
... highlight Pain Awareness Month in September, The ... interdisciplinary organization devoted to the field of aging is ... for seniors. Paired with its other recent research findings, ... advances in pain prevention, treatment, and management may improve care ...
Cached Medicine News:Health News:Gene Variant May Raise Death Risk After Heart Bypass 2Health News:Researchers identify potential molecular target to prevent growth of cancer cells 2Health News:National Cancer Institute establishes $11.3 million center at Case Western Reserve 2Health News:National Cancer Institute establishes $11.3 million center at Case Western Reserve 3Health News:National Cancer Institute establishes $11.3 million center at Case Western Reserve 4Health News:National Cancer Institute establishes $11.3 million center at Case Western Reserve 5Health News:National Cancer Institute establishes $11.3 million center at Case Western Reserve 6Health News:Genetics may explain why calcium increases risk for prostate cancer 2Health News:Genetics may predict why calcium increases risk for prostate cancer 2Health News:GSA sets focus on optimizing older adults' pain care 2
... super-light polypropylene mesh which offers an excellent ... considerably. Optilene Mesh LP is the alternative ... procedures. It perfectly conforms,to anatomical structures. Due ... adapts to the movements of the patient ...
... LP is a lightweight polypropylene mesh ... considerably reduced,foreign body reaction. The softer, ... It perfectly conforms to,anatomical structures. Due ... LP adapts to the movements of ...
... The Celsius Control System ... that can safely,and rapidly lower ... chosen target temperature and,rewarm patients ... Control System consists of an ...
... pump" coronary artery surgery is the latest ... is being embraced world-wide by increasing numbers ... subtle but reduced mortality, stroke, and bleeding ... benefits. A cardiac stabilizer is mandatory for ...
Medicine Products: